Metformin and Atorvastatin in Major Depression: The Hearts and Minds double-blind, randomised, placebo-controlled trial. : Hearts and Minds: A 3-arm Multicentre, Randomised, Double-Blind, Placebo-Controlled Study of Metformin and Atorvastatin for the Treatment of Depression in adults diagnosed with moderate to severe depression.

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 21. Juni Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Major Depressive Disorder; Major Depressive Disorder;Mental Health - Depression
Phase: Phase 2/Phase 3
Recruitment Status: Not yet recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 05-06-2023, Last updated: 2023-06-29

ICTRP ID:

ACTRN12623000611628
Nil Known

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO009304274